EIT Health Germany’s Expert Panel
Jury & Reviewer Pool
- Daniela Amann, Geschäftsbereichsleiterin Kundenbindung & Versorgung, Die Schwenninger Krankenkasse
- Dr. med. Rolf Baß, Adjunct Professor for Pharmaceutical and Toxicology, Charité, Universitätsmedizin Berlin
- Dr. Siegfried Bialojan, Executive Director, Ernst & Young GmbH, Head Life Science Center
- Dr. Elmar Bourdon, Manager, Mannheim Medical Technology Cluster, Office of Economic Development, City of Mannheim
- Prof. Horst Domdey, Managing Director, BioM Biotech Cluster Development GmbH
- Dr. Gerald Drewes, Head of Science, Cellzome GSK
- Dr. Peter Haug, Head of Business Development & Licensing, Oncgnostics GmbH
- Dr. Peter Johann, Managing General Partner, NGN Capital LLC
- Dr. Bernhard Kirschbaum, Protagen Diagnostics & Omeicos Therapeutics
- Dr. Oliver Ladendorf, Patentanwalt & European Patent Attorney, Kraus & Weisert
- Dr. Peter Müller, CEO, Stiftung Gesundheit
- Prof. Dr. med. Dr. rer. pol. Konrad Obermann, Senior Lecturer at the MIPH (Mannheim Institute of Public Health), University of Heidelberg & Consultant in international health economics, health care financing and social protection
- Dr. Patrick Pfeffer, CEO, aescuvest
- Dr. Andreas Rauh, Managing Partner, Management Institut für den Mittelstand
- Dr. Philipp Rittershaus, Investment Manager, High-Tech Gründerfonds
- Kurt Schlegel, Wirtschaftssenior, Aktivitäten u.a. Industrie 4.0 / IT Sicherheit
- Prof. Dr. Freimut Schliess, Director Science & Innovation, Profil Insitut für Stoffwechselforschung GmbH
- Dr. Stefan Simianer, General Manager, Research & Development, AbbVie Deutschland GmbH & Co. KG
- Dr. Matthias Stein-Gerlach, Patent & Licensing Manager, Max-Planck Innovation GmbH